| Product Code: ETC7635354 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Neuropathic Pain Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Neuropathic Pain Market - Industry Life Cycle |
3.4 Ireland Neuropathic Pain Market - Porter's Five Forces |
3.5 Ireland Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Ireland Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Ireland Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Ireland Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 Ireland Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 Ireland Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 Ireland Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuropathic pain in Ireland |
4.2.2 Growing awareness and diagnosis of neuropathic pain conditions |
4.2.3 Advancements in healthcare infrastructure and technology for pain management |
4.3 Market Restraints |
4.3.1 High cost of neuropathic pain treatments |
4.3.2 Limited access to specialized healthcare providers for neuropathic pain management |
4.3.3 Regulatory challenges and approval processes for new pain management therapies |
5 Ireland Neuropathic Pain Market Trends |
6 Ireland Neuropathic Pain Market, By Types |
6.1 Ireland Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 Ireland Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 Ireland Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 Ireland Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 Ireland Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Ireland Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 Ireland Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Ireland Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 Ireland Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 Ireland Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 Ireland Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 Ireland Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 Ireland Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 Ireland Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 Ireland Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 Ireland Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 Ireland Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 Ireland Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 Ireland Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 Ireland Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 Ireland Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 Ireland Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 Ireland Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 Ireland Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 Ireland Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 Ireland Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 Ireland Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 Ireland Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 Ireland Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 Ireland Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Neuropathic Pain Market Import-Export Trade Statistics |
7.1 Ireland Neuropathic Pain Market Export to Major Countries |
7.2 Ireland Neuropathic Pain Market Imports from Major Countries |
8 Ireland Neuropathic Pain Market Key Performance Indicators |
8.1 Patient-reported pain relief and improvement in quality of life |
8.2 Adoption rate of innovative pain management technologies and therapies |
8.3 Healthcare professionals' awareness and education on neuropathic pain management |
9 Ireland Neuropathic Pain Market - Opportunity Assessment |
9.1 Ireland Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Ireland Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Ireland Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Ireland Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 Ireland Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 Ireland Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 Ireland Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Ireland Neuropathic Pain Market - Competitive Landscape |
10.1 Ireland Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 Ireland Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here